| ATCC | American type culture collection |
| BHP | benign prostatic hyperplasia |
| Bmax | maximum receptor density |
| CT | computer tomography |
| DRE | digital rectal examination |
| EDDA | N,N-diacetic acid |
| FBS | fetal bovine serum |
| GCPII | glutamate carboxypeptidase II |
| HBED-CC | N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylene diamine-N,N′-diacetic acid |
| HPLC | high-performance liquid chromatography |
| HYNIC | 2-hydrazinonicotinic acid |
| IC50 | binding affinities |
| ID | injected dose |
| i.v. | intravenous |
| Kd | dissociation equilibrium constant |
| L-2NaI | naphthylalanine |
| LC-MS | liquid chromatopgraphy-mass spectrometry |
| LNCaP | lymph node carcinoma of the prostate |
| logD | partition coefficients |
| L-Trp | L-tryptophan |
| mCRPCa | metastatic castration-resistance prostate cancer |
| MRI | magnetic resonance imaging |
| MS | mass spectroscopy |
| NAALADase | glutamate carboxypeptidase II |
| NMR | nuclear magnetic resonance |
| p | probability value |
| PBS | phosphate buffer saline |
| PC3 | human prostate cancer cell line |
| PCa | prostat cancer |
| PET-CT | positron emission tomography—computed tomography |
| PSA | prostate-specific antigen |
| PSMA | prostate-specific membrane antigen |
| RCP | radiochemical purity |
| Rt | retention time |
| SD | standard deviation |
| SPECT | single-photon emission computed tomography |
| TLC | thin layer chromatography |
| US | ultrasound |